Tropomyosin1 isoforms underlie epithelial to mesenchymal plasticity, metastatic dissemination, and resistance to chemotherapy in high-grade serous ovarian cancer

Tong Xu,Mathijs P. Verhagen,Miriam Teeuwssen,Wenjie Sun,Rosalie Joosten,Andrea Sacchetti,Patricia C. Ewing-Graham,Maurice P. H. M. Jansen,Ingrid A. Boere,Nicole S. Bryce,Jun Zeng,Herbert R. Treutlein,Jeff Hook,Edna C. Hardeman,Peter W. Gunning,Riccardo Fodde

DOI: https://doi.org/10.1038/s41418-024-01267-9

IF: 12.067

2024-02-17

Cell Death and Differentiation

Abstract:Phenotypic plasticity, defined as the ability of individual cells with stable genotypes to exert different phenotypes upon exposure to specific environmental cues, represent the quintessential hallmark of the cancer cell en route from the primary lesion to distant organ sites where metastatic colonization will occur. Phenotypic plasticity is driven by a broad spectrum of epigenetic mechanisms that allow for the reversibility of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions (EMT/MET). By taking advantage of the co-existence of epithelial and quasi-mesenchymal cells within immortalized cancer cell lines, we have analyzed the role of EMT-related gene isoforms in the regulation of epithelial mesenchymal plasticity (EMP) in high grade serous ovarian cancer. When compared with colon cancer, a distinct spectrum of downstream targets characterizes quasi-mesenchymal ovarian cancer cells, likely to reflect the different modalities of metastasis formation between these two types of malignancy, i.e. hematogenous in colon and transcoelomic in ovarian cancer. Moreover, upstream RNA-binding proteins differentially expressed between epithelial and quasi-mesenchymal subpopulations of ovarian cancer cells were identified that underlie differential regulation of EMT-related isoforms. In particular, the up- and down-regulation of RBM24 and ESRP1, respectively, represent a main regulator of EMT in ovarian cancer cells. To validate the functional and clinical relevance of our approach, we selected and functionally analyzed the Tropomyosin 1 gene ( TPM1 ), encoding for a protein that specifies the functional characteristics of individual actin filaments in contractile cells, among the ovarian-specific downstream AS targets. The low-molecular weight Tpm1.8/9 isoforms are specifically expressed in patient-derived ascites and promote invasion through activation of EMT and Wnt signaling, together with a broad spectrum of inflammation-related pathways. Moreover, Tpm1.8/9 expression confers resistance to taxane- and platinum-based chemotherapy. Small molecule inhibitors that target the Tpm1 isoforms support targeting Tpm1.8/9 as therapeutic targets for the development of future tailor-made clinical interventions.

cell biology,biochemistry & molecular biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore how specific actin - binding protein Tropomyosin 1 (TPM1) isoforms enhance tumor cell invasiveness and chemoresistance in high - grade serous ovarian cancer (HGSOC) by promoting epithelial - mesenchymal transition (EMT), activating the Wnt signaling pathway, and widely activating inflammation - related pathways. Specifically, the paper mainly focuses on the specific expression of low - molecular - weight TPM1 isoforms Tpm1.8/9 in patient - derived ascites and studies the mechanism of action of these isoforms in HGSOC cells and their potential as future therapeutic targets.

The paper explored the role of these cells in tumor metastasis and chemoresistance by analyzing the quasi - mesenchymal cell subpopulations in HGSOC cell lines. The study found that, compared with epithelial cells, quasi - mesenchymal cells showed stronger migration and invasion abilities, and there were differentially expressed RNA - binding proteins (such as RBM24 and ESRP1) in these cells, and these proteins regulated the alternative splicing of EMT - related genes. In particular, the up - regulation of Tpm1.8/9 isoforms was related to EMT induction, activation of the Wnt signaling pathway, and chemoresistance. In addition, the paper also verified the effect of Tpm1.8/9 isoform overexpression on the invasion ability and metastasis formation of HGSOC cells through in vivo experiments, as well as the expression of these isoforms in patient - derived ascites.

In summary, this paper aims to reveal the biological functions of TPM1 isoforms in HGSOC, especially how they affect tumor invasiveness, metastatic ability, and response to chemotherapy, thereby providing a theoretical basis for the development of new treatment strategies.